Search results
Results from the WOW.Com Content Network
Budesonide, sold under the brand name Pulmicort, among others, is a steroid medication. [8] It is available as an inhaler, nebulization solution, pill, nasal spray, and rectal forms. [8][9] The inhaled form is used in the long-term management of asthma and chronic obstructive pulmonary disease (COPD). [8][10][11] The nasal spray is used for ...
Budesonide/formoterol, sold under the brand name Symbicort among others, is a fixed-dose combination medication used in the management of asthma or chronic obstructive pulmonary disease (COPD). [2] It contains budesonide, a steroid and formoterol, a long-acting β 2 -agonist (LABA). [2] The product monograph does not support its use for sudden ...
Pregnancy category. The pregnancy category of a medication is an assessment of the risk of fetal injury due to the pharmaceutical, if it is used as directed by the mother during pregnancy. It does not include any risks conferred by pharmaceutical agents or their metabolites in breast milk.
Ciclesonide, sold under the brand name Omnaris among others, is a glucocorticoid used to treat asthma and allergic rhinitis. Side effects of the medication include headache, nosebleeds, and inflammation of the nose and throat linings. [6] It was patented in 1990 and approved for medical use in 2005. [7]
Clobetasol propionate is a corticosteroid used to treat skin conditions such as eczema, contact dermatitis, seborrheic dermatitis, steroid responsive dermatosis, and psoriasis (including scalp and plaque-type). [3][4][5] It is applied to the skin as a cream, foam, gel, liquid, solution, ointment, or shampoo. [4][6][5] Use should be short term ...
Summary chart: A summary chart that is color coded, with green used for category 1 and 2 methods and pink/red used for category 3 and 4 methods, exists to provide reference to select methods and their categories. Summary wheel: A summary wheel exists that details categories in a slightly different format than the summary chart. [4]
Potassium supplementation only at levels below 3.6 mEq/L may help prevent atrial fibrillation ... Estimates suggest that it affects up to 3% of the Western population ages 20 years or older.
Safety in pregnancy and breastfeeding is unclear. [6] Fluticasone, a corticosteroid, works by decreasing inflammation while salmeterol, a long-acting beta-adrenoceptor agonist (LABA), works by activating beta-2 adrenergic receptors. [5] The combination was approved for medical use in the United States in 2000. [5]